| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |